177 related articles for article (PubMed ID: 15968907)
1. [Update on the anesthetic management of patients with malignant carcinoid syndrome].
Rodríguez-Cosmen C; Trillo Urrutia L; Pacreu Terradas S; Comps Vicente O; Escolano Villén F
Rev Esp Anestesiol Reanim; 2005 May; 52(5):291-4. PubMed ID: 15968907
[TBL] [Abstract][Full Text] [Related]
2. Octreotide treatment of carcinoid hypertensive crisis.
Warner RR; Mani S; Profeta J; Grunstein E
Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
[TBL] [Abstract][Full Text] [Related]
3. Anesthetic considerations and management of a patient with unsuspected carcinoid crisis during hepatic tumor resection.
Choi CK
Middle East J Anaesthesiol; 2014 Jun; 22(5):515-8. PubMed ID: 25137869
[TBL] [Abstract][Full Text] [Related]
4. Uneventful spinal anesthesia for a patient with carcinoid syndrome managed with long-acting octreotide.
Orbach-Zinger S; Lombroso R; Eidelman LA
Can J Anaesth; 2002; 49(7):678-81. PubMed ID: 12193484
[TBL] [Abstract][Full Text] [Related]
5. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
[TBL] [Abstract][Full Text] [Related]
6. Update on carcinoid syndrome.
Melnyk DL
AANA J; 1997 Jun; 65(3):265-70. PubMed ID: 9233098
[TBL] [Abstract][Full Text] [Related]
7. [Anaphylactic reaction versus carcinoid crisis: the role of octreotide as a vasoconstrictor].
Etxaniz Alvarez A; Pita Zapata E; González Vázquez M; López Pérez M; Abeledo Fernánndez MA
Rev Esp Anestesiol Reanim; 2004; 51(7):395-8. PubMed ID: 15495639
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
Condron ME; Pommier SJ; Pommier RF
Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
[TBL] [Abstract][Full Text] [Related]
9. Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review.
Seymour N; Sawh SC
Can J Anaesth; 2013 May; 60(5):492-9. PubMed ID: 23328959
[TBL] [Abstract][Full Text] [Related]
10. Carcinoid crisis 24 hours after bland embolization: A case report.
Fujie S; Zhou W; Fann P; Yen Y
Biosci Trends; 2010 Jun; 4(3):143-4. PubMed ID: 20592464
[TBL] [Abstract][Full Text] [Related]
11. Development of effective prophylaxis against intraoperative carcinoid crisis.
Woltering EA; Wright AE; Stevens MA; Wang YZ; Boudreaux JP; Mamikunian G; Riopelle JM; Kaye AD
J Clin Anesth; 2016 Aug; 32():189-93. PubMed ID: 27290972
[TBL] [Abstract][Full Text] [Related]
12. Carcinoid tumor and intravenous octreotide infusion during labor and delivery.
Le BT; Bharadwaj S; Malinow AM
Int J Obstet Anesth; 2009 Apr; 18(2):182-5. PubMed ID: 19200714
[TBL] [Abstract][Full Text] [Related]
13. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
Massimino K; Harrskog O; Pommier S; Pommier R
J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
[TBL] [Abstract][Full Text] [Related]
14. Reversible parkinsonism and ataxia associated with high-dose octreotide.
Espay AJ
Neurology; 2008 Jun; 70(24):2345-6. PubMed ID: 18463367
[No Abstract] [Full Text] [Related]
15. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
[TBL] [Abstract][Full Text] [Related]
16. Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide.
Pavlovic M; Saiag P; Lotz JP; Marinho E; Clerici T; Izrael V
Arch Dermatol; 1995 Oct; 131(10):1207-9. PubMed ID: 7574845
[No Abstract] [Full Text] [Related]
17. [Symptomatic treatment of the malignant carcinoid syndrome with octreotide].
Alberts AS; Falkson G
S Afr Med J; 1989 Jan; 75(1):30-1. PubMed ID: 2911781
[TBL] [Abstract][Full Text] [Related]
18. mTOR inhibitor therapy for patients with carcinoid.
Rindi G; Caplin M
Lancet; 2011 Dec; 378(9808):1978-1980. PubMed ID: 22119494
[No Abstract] [Full Text] [Related]
19. Case report--carcinoid syndrome: two case reports from reserve unit.
Smith DF
J R Nav Med Serv; 2011; 97(2):66-71. PubMed ID: 22013639
[TBL] [Abstract][Full Text] [Related]
20. Remifentanil and anaesthesia for carcinoid syndrome.
Farling PA; Durairaju AK
Br J Anaesth; 2004 Jun; 92(6):893-5. PubMed ID: 15033895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
